Esperion Therapeutics, Inc. share price logo

Esperion Therapeutics, Inc. Share Price

NASDAQ: ESPR

Small Cap

$2.78

as on

Esperion Therapeutics, Inc. Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.7
    $2.82
    downward going graph

    2.88%

    Downside

    1.44%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.69
    $3.94
    downward going graph

    75.09%

    Downside

    41.73%

    Upside

    downward going graph

Esperion Therapeutics, Inc. share price movements today

Previous Close
$2.78
Open
$2.79
Volume
6.0M
Day's Low - High
$2.7 - $2.82
52 Week Low - High
$0.69 - $3.94

Esperion Therapeutics, Inc. Historical Returns

1 Month Return
+ 35.12 %
3 Month Return
+ 154.13 %
1 Year Return
+ 55.62 %
3 Year Return
-60.49 %
5 Year Return
-92.68 %

Esperion Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Esperion Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$560.5M

EPS (TTM)

-0.0167

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.49

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

-4.78

EBITDA

-35.3M

Revenue (TTM)

268.1M

Profit Margin

-38.80%

Return On Equity TTM

43097300.00%

Esperion Therapeutics, Inc. Stock Valuation

Track how Esperion Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Esperion Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-3.49x)

September 17, 2025

Highest (-0.50x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -3.49x

Esperion Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Esperion Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$560.5M-92.68%-3.49-38.80%
BUY$18.0BNA15.5240.36%
BUY$44.0BNA21.5113.81%
BUY$14.0B38.31%41.6913.88%
BUY$65.4B-8.86%25.3827.83%

Stock Returns calculator for Esperion Therapeutics, Inc. Stock including INR - Dollar returns

The Esperion Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Esperion Therapeutics, Inc. investment value today

Current value as on today

₹1,61,047

Returns

₹61,047

(+61.05%)

Returns from Esperion Therapeutics, Inc. Stock

₹56,180 (+56.18%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Esperion Therapeutics, Inc. Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Esperion Therapeutics, Inc.. Average target price of $5.8

Esperion Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Esperion Therapeutics, Inc..

What analysts predicted

52.07%UPSIDE

Target Price

$5.8

Current Price

$2.78

Analyzed by

14 Analysts

Target

$5.80

Esperion Therapeutics, Inc. target price $5.8, a slight upside of 52.07% compared to current price of $2.78. According to 14 analysts rating.

Esperion Therapeutics, Inc. Stock's Interest Amongst Investors

Investment in Esperion Therapeutics, Inc. Shares on INDmoney has grown by 33.33% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:33.33% versus previous 30 day period

Search interest for Esperion Therapeutics, Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

Esperion Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
24
25
33
32
137
73
51
69
64
82
Gross Profit
12
19
20
20
127
58
34
43
33
61
Operating Income
-48
-37
-27
-42
72
2
-16
-4
-22
15
EBITDA
-47
-35
-26
-41
75
-48
-14
-4
-20
15
Interest Expense
14
14
14
15
14
13
15
16
19
20
Depreciation
0
0
0
0
-
0
0
0
0
0
Income Before Tax
-61
-49
-41
-56
61
-61
-29
-21
-40
-4
Income Tax Expense
27
0
0
-27
0
-
-29
-
-
-
Net Income
-89
-49
-41
-56
61
-61
-29
-21
-40
-4
Net Profit Margin
-366.72%
-193.65%
-121.43%
-174.71%
44.30%
-83.87%
-57.18%
-30.85%
-62.24%
-5.82%

Esperion Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
184
148
227
78
75
116
332
Gross Profit
0
0
0
184
-27
225
64
48
73
263
Operating Income
-50
-76
-168
-204
-93
-121
-226
-179
-155
54
EBITDA
-49
-74
-166
-204
-88
-120
-222
-176
-150
7
Interest Expense
0
0
0
0
8
22
46
56
58
59
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-49
-74
-166
-201
-97
-143
-269
-233
-209
-51
Income Tax Expense
1
1
2
2
11
22
49
54
0
-51
Net Income
-49
-74
-166
-201
-109
-166
-318
-287
-209
-51
Net Profit Margin
0.00%
0.00%
0.00%
-109.40%
-73.48%
-73.04%
-406.42%
-381.34%
-179.87%
-15.57%

Esperion Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-49
-41
-56
61
-61
-29
-21
-40
-12
Operating Cash Flow
-24
-19
-37
53
-7
-35
-34
-22
-31
Investing Cash Flow
17
-
-
0
0
0
-
-
-
Financing Cash Flow
0
-4
4
90
-30
-9
34
-7
2
Change in Cash
-6
-23
-32
144
-37
-44
0
-30
-28

Esperion Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-74
-166
-201
-97
-143
-269
-233
-209
-51
Operating Cash Flow
-47
-131
-148
-70
-85
-263
-174
-135
-23
Investing Cash Flow
10
-35
140
64
21
-50
8
42
0
Financing Cash Flow
-1
163
10
136
201
268
32
50
86
Change in Cash
-39
-3
2
130
137
-46
-134
-42
62

Global Institutional Holdings in Esperion Therapeutics, Inc.

Funds
Holdings
BlackRock Inc
7.24%
Vanguard Group Inc
5.74%
Wasatch Advisors LP
5.46%
Bellevue Group AG
4.84%
Two Seas Capital LP
3.46%

Insights on Esperion Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -40.45M → -4.79M (in $), with an average increase of 744.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 64.99M → 82.38M (in $), with an average increase of 21.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ESPR stock has moved up by 35.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ESPR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 82.5% return, outperforming this stock by 143.0%

About Esperion Therapeutics, Inc.

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa reductase, the enzyme target of statins. the company has successfully completed its phase 1 and phase 2 development programs for etc-1002, and plans to initiate its etc-1002 phase 3 development program by the end of 2015. for more information, please visit www.esperion.com.
OrganisationEsperion Therapeutics, Inc.
Headquarters3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
IndustryHealth Technology
CEOMr. Sheldon L. Koenig
E-voting on sharesClick here to vote

Key Management of Esperion Therapeutics, Inc.

Name

Title

Dr. Stephen Pinkosky

Vice President of Drug Discovery of Early Pre-Clinical Development

Mr. Sheldon L. Koenig

President, CEO & Director

Mr. Benjamin Halladay M.B.A.

Chief Financial Officer

Mr. Benjamin O. Looker J.D.

General Counsel & Corporate Secretary

Tiffany Aldrich M.B.A.

Associate Director of Corporate Communications

Ms. Betty Jean Swartz

Chief Business Officer

Mr. Glenn P. Brame

Chief Technical Operations Officer

FAQs

What is Esperion Therapeutics, Inc. share price today?

Esperion Therapeutics, Inc. share price today is $2.78 as on at the close of the market. Esperion Therapeutics, Inc. share today touched a day high of $2.82 and a low of $2.7.

What is the 52 week high and 52 week low for Esperion Therapeutics, Inc. share?

Esperion Therapeutics, Inc. share touched a 52 week high of $3.94 on and a 52 week low of $0.69 on . Esperion Therapeutics, Inc. stock price today i.e. is closed at $2.78,which is 29.44% down from its 52 week high and 301.44% up from its 52 week low.

What is Esperion Therapeutics, Inc.'s market capitalisation today?

Esperion Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Esperion Therapeutics, Inc. Stock (ESPR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Esperion Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Esperion Therapeutics, Inc. Shares that will get you 0.5396 shares as per Esperion Therapeutics, Inc. share price of $2.78 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Esperion Therapeutics, Inc. Stock (ESPR) from India?

Indian investors can start investing in Esperion Therapeutics, Inc. (ESPR) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Esperion Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Esperion Therapeutics, Inc. share’s latest price of $2.78 as on September 17, 2025 at 1:29 am IST, you will get 3.5971 shares of Esperion Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Esperion Therapeutics, Inc. has given to Indian investors in the last 5 years?

Esperion Therapeutics, Inc. stock has given -92.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?